ECONOMIC CONSEQUENCES OF POORLY CONTROLLED PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE IN GERMANY, ITALY AND SPAIN
Author(s)
Darba J1, Restovic G2, Kaskens L2, Plans P31Universitat de Barcelona, Barcelona, Spain, 2BCN Health, Barcelona, Spain, 3Generalitat de Catalunya, Barcelona, Spain
OBJECTIVES: The aim of this study was to estimate the implications of poorly controlled GERD for patients and the economic implications for health care providers and employers in Germany, Italy and Spain. METHODS: Based on population figures, prevalence and incidence for GERD and its implications and cost data, the number of patients with poorly treated GERD and their implications, as well as the economic consequences for health services and employers were calculated for each country. RESULTS: The amount of patients with poorly treated GERD that have severe esophagitis are estimated to be 740,364 in Germany, 240,559 in Italy and 225, 054 in Spain per year. The number of patients with Barrett's oesophagus are estimated to be 29,678 in Spain, 19,327 in Germany and 10,079 in Italy. The number of patients with adenocarcinoma are around 483 patients in Germany, 142 in Spain, and 53 in Italy. Costs for poorly treated GERD patients for the health services were estimated to be €18 million for Spain, €12 million for Germany and €7 million for Italy. Absenteeism and presenteeism costs due to poorly controlled GERD for employers were almost none. CONCLUSIONS: Costs for complications in patients with poorly controlled GERD added costs for health care systems for all three countries but almost no extra costs were found for employers.
Conference/Value in Health Info
2010-11, ISPOR Europe 2010, Prague, Czech Republic
Value in Health, Vol. 13, No. 7 (November 2010)
Code
PGI12
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Gastrointestinal Disorders